About Prof. Dr. Med. Lothar Schweigerer
Prof. Dr. med. Lothar Schweigerer is an internationally respected German General Paediatrician and Pediatric Medical Oncologist based in Berlin, widely recognised as a leading General Paediatrician, Medical Oncologist specialist in Berlin, Germany for pediatric oncology, neuroblastoma, pediatric hematology, and childhood cancer research.
- 40+ years of clinical and academic experience in pediatric oncology
- Former Chief & Executive Medical Director, Children's Hospital at Helios Klinikum Berlin-Buch (2006–2019)
- Full Professor of Pediatrics and Pediatric Hematology/Oncology
- 90+ peer-reviewed scientific publications on neuroblastoma, angiogenesis, and childhood cancers
- Winner of Young Investigator Award (ESMO), Kind Philipp Foundation Prize, and Gerhard Domagk Prize
Qualifications & Credentials
Medical Degrees
- Medical License / Medical Graduation (MD) — Justus Liebig University Giessen, Germany (1973–1980)
- Doctorate (Dr. med.) — Germany
- Postdoctoral Fellow in Cancer Research — University of California Medical Center, San Francisco, USA (1984–1987)
- Postdoctoral Research — German Cancer Research Center (DKFZ), Heidelberg, Germany, 1987
- Full Professorship in Pediatrics and Pediatric Hematology/Oncology
Fellowships & Special Training
- Basic medical and surgical education — University of Giessen, Germany, 1970–1983
- Specialization in Medical Oncology — Ruprecht Karls University of Heidelberg, 1984–1987
- Research Fellow — DKFZ German Cancer Research Center (1987)
- Clinical education in Pediatrics — Children's Hospital of the University of Heidelberg
- Senior Physician training — Children's Hospitals of the Universities of Marburg and Essen
Certifications & Accreditations
- German Medical Association (Bundesärztekammer) Registration
- Board-Certified Specialist — Pediatrics and Adolescent Medicine, Germany
- Board-Certified Specialist — Pediatric Hematology and Oncology, Germany
- Full Professor — Pediatrics and Pediatric Hematology/Oncology
Areas of Expertise
Major Conditions Treated
- Neuroblastoma (Most Common Solid Extra-Cranial Tumor of Infancy)
- Pediatric Hodgkin Lymphoma
- Pediatric Non-Hodgkin Lymphoma
- Pediatric Leukemia
- Langerhans Cell Histiocytosis
- Alveolar Rhabdomyosarcoma
- Ganglioneuroma & Ganglioneuroblastoma
- Wilms' Tumor
- Pediatric Hematologic Disorders
- Pediatric Solid Tumors
- Rare Childhood Cancers
- General Pediatric Conditions
Sub-specialties
- Pediatric Medical Oncology: Comprehensive medical management of childhood cancers with focus on rare solid tumors — a trusted general paediatrician, medical oncologist specialist in Berlin, Germany.
- Neuroblastoma Research & Care: International authority on neuroblastoma, MYCN oncogene amplification, and angiogenesis in pediatric cancer.
- Pediatric Hematology: Expert management of pediatric hematologic disorders and coagulation factor deficiencies.
- Molecular Biology & Translational Oncology: Extensive research in cell biology, cancer research, and molecular biology of childhood cancers — for international patients seeking best pediatric cancer treatment in Germany.
- Rare Childhood Tumors: Specialised interest in pediatric rare tumours as part of the German Society for Pediatric Oncology and Hematology (GPOH).
- Children's Rights Advocacy: Active voice for pediatrics and the rights of sick children and adolescents.
Advanced Procedures & Treatments
- Pediatric Systemic Chemotherapy
- Pediatric Targeted Therapy
- Pediatric Stem Cell Transplantation Coordination
- Pediatric Immunotherapy
- Neuroblastoma Multimodal Therapy
- Pediatric Hodgkin Lymphoma Circulating Cell-Free DNA Monitoring
- Whole-Body Imaging for Pediatric Rhabdomyosarcoma Staging
- Pediatric Palliative Care Coordination
- Clinical Trial Enrolment for Innovative Pediatric Therapies
- Germline Genetic Counselling for Pediatric Cancer Predisposition
- Multidisciplinary Pediatric Tumour Board Management
List of Disease and Treatment for which Prof. Dr. Med. Lothar Schweigerer can be consulted
Professional Experience
Current Affiliation
- medudoc Group (Digital Health / Informed Consent Platform) — Senior Medical Officer / Spokesperson of the Medical Advisory Board, Berlin, Present
- Senior Consultant — Pediatric Hospital & Oncology Research Collaborations
Past Affiliations
- Helios Klinikum Berlin-Buch — Chief and Executive Medical Director, Children's Hospital & Full Professor, October 2006–June 2019 (almost 20 years of leadership of the newly-built hospital)
- University of Göttingen — Chief & Executive Director, Hospital for Children and Adolescents & Full Professor, 2002–2006
- University of Essen — Chief Resident & Assistant Professor, Hospital for Children and Adolescents, 1997–2002
- University of Marburg — Chief Resident & Associate Professor, Hospital for Children and Adolescents, 1994–1997
- University of Heidelberg — Intern and Resident, Hospital for Children and Adolescents, 1987–1994
- DKFZ German Cancer Research Center — Postdoctoral Researcher, 1987
- University of California, San Francisco — Postdoctoral Fellow in Cancer Research, 1984–1987
- Additional senior consultancy — Frankfurt Hospital (since 2019)
Academic & Research Roles
- Full Professor of Pediatrics and Pediatric Hematology/Oncology
- Chair — Children's Hospital, Helios Klinikum Berlin-Buch (2006–2019)
- Research affiliations — EDU Medicine Institute, ICEK Buch Association, European Medical Oncology Federation
- Author — 90+ peer-reviewed scientific publications
- Research focus — Cell biology, cancer research, molecular biology
- Advocate — Children's rights and pediatric rare tumours
- Initiator — Music and entertainment programme for pediatric patients at Helios Klinikum Berlin-Buch
Key Achievements
- 40+ years of clinical and academic experience
- 17+ years as Chief of Children's Hospital at Helios Klinikum Berlin-Buch
- Pioneer in pediatric neuroblastoma research (MYCN, angiogenesis, activin A)
- 90+ scientific publications and extensive international research network
- International training at UCSF (USA) and DKFZ (Germany)
- Chair positions at four major German University Children's Hospitals
Awards & Recognitions
National & International Awards
- Young Investigator Award — European Society for Medical Oncology (ESMO)
- Science Prize — Kind Philipp Foundation for Leukemia Research
- Gerhard Domagk Prize
- Award — Dr. Heinz and Helene Adam Foundation
Professional Memberships
- European Medical Oncology Federation — Member
- German Society for Pediatric Oncology and Hematology (GPOH) — Member
- International Society for Pediatric Oncology (SIOP) — Member
- EDU Medicine Institute — Affiliated Expert
- ICEK Buch Association — Member
- German Medical Association (Bundesärztekammer)
Research & Publications
Published Papers (Selected)
- Schweigerer L et al. Research on STC2 (Stanniocalcin 2) in human neuroblastoma — metastatic stages and MYCN expression.
- Becker J, Volland S, Noskova I, Schramm A, Schweigerer L, Wilting J. "Keratoepithelin reverts the suppression of tissue factor pathway inhibitor 2 by MYCN in human neuroblastoma: a mechanism to inhibit invasion." Int J Oncol 32:235–240.
- Schramm A, von Schuetz V, Christiansen H, Havers W, Papoutsi M, Wilting J, Schweigerer L. "High activin A-expression in human neuroblastoma: suppression of malignant potential and correlation with favourable clinical outcome." Oncogene 24:680–687.
- Schweigerer L et al. Research on ganglioneuroma and ganglioneuroblastoma intermixed — treatment outcomes in collaboration with University of Cologne (German neuroblastoma trials, Deutsche Krebshilfe).
- Research on hypoxia-induced erythropoietin expression in human neuroblastoma requiring methylation-free HIF-1 binding site.
- Schweigerer L et al. Research on acquired deficiency of coagulation factor XIII and the link between coagulation and infection.
- 90+ peer-reviewed publications on neuroblastoma, angiogenesis, pediatric oncology, and molecular biology of childhood cancers.
Ongoing Research & Clinical Interests
- Neuroblastoma and MYCN oncogene amplification
- Angiogenesis in pediatric solid tumors
- Pediatric Hodgkin lymphoma circulating cell-free DNA
- Pediatric rare tumors and translational oncology
- Pediatric-onset multisystem Langerhans cell histiocytosis
- Children's rights advocacy and pediatric healthcare policy
Estimated Treatment Costs
| Procedure / Consultation | Estimated Cost (INR) | Estimated Cost (USD) |
|---|---|---|
| Pediatric Oncology Consultation (Germany) | ₹15,000 – ₹35,000 | $180 – $420 |
| Neuroblastoma Multimodal Treatment (per year) | ₹30,00,000 – ₹80,00,000 | $36,000 – $96,000 |
| Pediatric Chemotherapy (per year) | ₹15,00,000 – ₹40,00,000 | $18,000 – $48,000 |
| Pediatric Stem Cell Transplantation | ₹35,00,000 – ₹75,00,000 | $42,000 – $90,000 |
| Pediatric Immunotherapy (per year) | ₹25,00,000 – ₹60,00,000 | $30,000 – $72,000 |
| Whole-Body MRI for Rhabdomyosarcoma Staging | ₹60,000 – ₹1,80,000 | $720 – $2,160 |
*Indicative estimates only. Actual costs subject to hospital pricing, case complexity, and insurance. Contact Cancer Rounds for a personalised quote.
Frequently Asked Questions
1. What advanced technologies does Prof. Dr. Med. Lothar Schweigerer use in General Paediatrician, Medical Oncologist treatment?
Prof. Dr. med. Lothar Schweigerer uses advanced pediatric multimodal therapy, modern pediatric targeted therapy and immunotherapy, pediatric stem cell transplantation coordination, hybrid capture-targeted next-generation sequencing of circulating cell-free DNA for pediatric Hodgkin lymphoma, whole-body imaging for rhabdomyosarcoma staging, and comprehensive molecular diagnostics — a cutting-edge toolkit that establishes him as a leading general paediatrician, medical oncologist specialist in Berlin, Germany.
2. What conditions does Prof. Dr. Med. Lothar Schweigerer specialize in treating?
Prof. Dr. med. Lothar Schweigerer specialises in neuroblastoma (the most common solid extra-cranial tumor of infancy), pediatric Hodgkin and non-Hodgkin lymphoma, pediatric leukemia, Langerhans cell histiocytosis, alveolar rhabdomyosarcoma, ganglioneuroma, Wilms' tumor, pediatric hematologic disorders, pediatric solid tumors, rare childhood cancers, and general pediatric conditions — comprehensive care for international patients seeking best pediatric cancer treatment in Germany.
3. How do I book an appointment with Prof. Dr. Med. Lothar Schweigerer?
Appointments with Prof. Dr. med. Lothar Schweigerer can be booked directly through the Cancer Rounds website or by contacting their international patient department for priority scheduling.
4. Can international patients receive treatment from Prof. Dr. Med. Lothar Schweigerer?
Yes. Cancer Rounds provides full assistance for international patients seeking treatment from Prof. Dr. med. Lothar Schweigerer, including medical visa invitation letters, airport transfers, and local accommodation coordination.
5. What support is available for international patients?
International patients benefit from a dedicated concierge service provided by Cancer Rounds, including language interpretation, financial counselling, and pre-travel virtual consultations to review medical records before arrival.
6. Does Prof. Dr. Med. Lothar Schweigerer offer second opinions for General Paediatrician, Medical Oncologist cases?
Yes. Second opinion consultations can be arranged via Cancer Rounds for patients who wish to review their diagnosis or treatment plan with an expert pediatric oncology specialist in Berlin, Germany, especially for complex neuroblastoma, pediatric Hodgkin lymphoma, Langerhans cell histiocytosis, and rare childhood cancer cases.
Charite University Hospital, Berlin - Germany
